Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Evolution of Anti-ADAMTS13 Antibodies in a Refractory Case of Thrombotic Thrombocytopenic Purpura with Fatal Outcome

Barbara Plaimauer, Paul Knoebl, Susanna Skalicky, Silvia Ferrari, Katalin Varadi, PhD, Vera Kolovratova, Peter L. Turecek, PhD, Manfred Rieger, Friedrich Scheiflinger

Blood (2008) 112 (11): 4568.

https://doi.org/10.1182/blood.V112.11.4568.4568

Published: 2008

Journal Articles

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Blood (2006) 109 (7): 2815–2822.

https://doi.org/10.1182/blood-2006-02-006064

Published: 2006

Journal Articles

Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation

Barbara Plaimauer, Jakob Fuhrmann, Gabriele Mohr, Waltraud Wernhart, Katharina Bruno, Silvia Ferrari, Christian Konetschny, Gerhard Antoine, Manfred Rieger, Friedrich Scheiflinger

Blood (2006) 107 (1): 118–125.

https://doi.org/10.1182/blood-2005-06-2482

Published: 2006

Journal Articles

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

Fadi Fakhouri, Jean-Paul Vernant, Agnès Veyradier, Martine Wolf, Gilles Kaplanski, Raynald Binaut, Manfred Rieger, Friedrich Scheiflinger, Pascale Poullin, Benjamin Deroure, Richard Delarue, Philippe Lesavre, Philippe Vanhille, Olivier Hermine, Giuseppe Remuzzi, Jean-Pierre Grünfeld

Blood (2005) 106 (6): 1932–1937.

https://doi.org/10.1182/blood-2005-03-0848

Published: 2005

Journal Articles

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Manfred Rieger, Pier Mannuccio Mannucci, Johanna A. Kremer Hovinga, Andrea Herzog, Gabi Gerstenbauer, Christian Konetschny, Klaus Zimmermann, Inge Scharrer, Flora Peyvandi, Miriam Galbusera, Giuseppe Remuzzi, Martina Böhm, Barbara Plaimauer, Bernhard Lämmle, Friedrich Scheiflinger

Blood (2005) 106 (4): 1262–1267.

https://doi.org/10.1182/blood-2004-11-4490

Published: 2005

Journal Articles

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Gerhard Antoine, Martin Hermann, Manfred Rieger, Friedrich Scheiflinger, Bernhard Lämmle

Blood (2005) 105 (2): 542–544.

https://doi.org/10.1182/blood-2004-06-2096

Published: 2005

Journal Articles

Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA.

Manfred Rieger, PhD, Silvia Ferrari, MS, Andrea Herzog, Christian Konetschny, PhD, Michael Dockal, PhD, Barbara Plaimauer, PhD, Friedrich Scheiflinger, PhD

Blood (2004) 104 (11): 3944.

https://doi.org/10.1182/blood.V104.11.3944.3944

Published: 2004

Journal Articles

Single Nucleotide Polymorphisms Influence the Phenotype of Mutations P618A and R1336W found in the ADAMTS13 Gene of Congenital TTP Patients.

Barbara Plaimauer, PhD, Gabriele Mohr, Waltraud Wernhart, Katharina Bruno, MSc, Gerhard Antoine, PhD, Manfred Rieger, PhD, Friedrich Scheiflinger, PhD

Blood (2004) 104 (11): 2977.

https://doi.org/10.1182/blood.V104.11.2977.2977

Published: 2004

Journal Articles

Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

Friedrich Scheiflinger, Paul Knöbl, Bettina Trattner, Barbara Plaimauer, Gabriele Mohr, Michael Dockal, Friedrich Dorner, Manfred Rieger

Blood (2003) 102 (9): 3241–3243.

https://doi.org/10.1182/blood-2003-05-1616

Published: 2003

Journal Articles

ADAMTS13 autoantibody detection by quantitative immunoblotting

Katalin Váradi, Jutta Schreiner, Barbara Plaimauer, Manfred Rieger, Fritz Scheiflinger, Paul Knöbl, Peter L. Turecek, Hans P. Schwarz

Blood (2003) 102 (5): 1932–1933.

https://doi.org/10.1182/blood-2003-05-1688

Published: 2003

NARROW

Evolution of Anti-ADAMTS13 Antibodies in a Refractory Case of Thrombotic Thrombocytopenic Purpura with Fatal Outcome

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA.

Single Nucleotide Polymorphisms Influence the Phenotype of Mutations P618A and R1336W found in the ADAMTS13 Gene of Congenital TTP Patients.

Nonneutralizing IgM and IgG antibodies to von Willebrand factor–cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

ADAMTS13 autoantibody detection by quantitative immunoblotting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only